KMT2D and breast carcinoma: In a breast cancer study, we showed that KMT2D knockdown inhibited cell proliferation and invasion of triple–negative breast cancer cell lines and that KMT2D and KMT2D-interacting histone demethylase UTX co-activated gene expression programs for cell proliferation and invasion [44].